Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Sever…

Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single ...
wqad

Bettendorf doctor helping reduce pain for knee replacement patients

BETTENDORF, Iowa — A UnityPoint Health - Trinity doctor is using an innovative procedure to improve recovery after a knee replacement surgery. Dr. Maruti Kari in the hospital's pain management clinic ...
Seeking Alpha

Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings

-- Beginning January 1, 2025, providers can receive additional Medicare payment when they use EXPAREL or iovera° via product-specific reimbursement codes -- PARSIPPANY, N.J., Nov. 04, 2024 (GLOBE ...
Nasdaq

Pacira, J&J MedTech Partner To Expand Reach Of ZILRETTA For Osteoarthritis Knee Pain

(RTTNews) - Pacira BioSciences (PCRX) has entered a strategic collaboration with Johnson & Johnson MedTech to co-promote ZILRETTA®, its extended-release intra-articular injection for osteoarthritis ...
Hosted on MSN

Knee arthritis made worse with steroid injections

Researchers comparing two injections commonly used to relieve knee pain from osteoarthritis—corticosteroid and hyaluronic acid—found that corticosteroid injections were associated with higher ...
Healio

Study finds cell-based therapy not superior to corticosteroid injection for knee OA

Please provide your email address to receive an email when new articles are posted on . Cell-based injections were not superior to corticosteroid injection for patients with knee OA. Pain scores and ...